Position in ABT
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$3,289,869
-$951,326 QoQ
Shares Held
36,256
-12.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#878
of 2,959 holders
Holding Since
Dec 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Boston Common Asset Management, LLC holds $17,837,103 across 2 Medical Devices names. ABT ranks #2 (18.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
160,814 | $14,547,234 | |
| 2 | ABT |
Abbott Laboratories
This page
|
36,256 | $3,289,869 |
All Filings in ABT
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,289,869 | 36,256 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $4,241,195 | 41,309 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $5,269,070 | 42,055 | Shares | Sole | 2026-05-07 | |
| 2025-09-30 | $6,113,423 | 45,643 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $3,316,059 | 24,381 | Shares | Sole | 2025-07-22 | |
| 2022-12-31 | $687,175 | 6,259 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $592,364 | 6,122 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $658,201 | 6,058 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $656,542 | 5,547 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $873,995 | 6,210 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $695,549 | 5,888 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $680,509 | 5,870 | Shares | Sole | 2021-08-19 | |
| 2021-03-31 | $653,128 | 5,450 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $591,464 | 5,402 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||